Nifedipine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67877-756 -
Package NDC
67877-756-01 -
Package NDC
67877-756-05 -
Package NDC
67877-756-58 -
Package NDC
67877-756-90 -
Application number
ANDA216067 -
SPL ID
2833cb85-4017-41e2-aa4a-c19371ba85e8 -
SPL set ID
f661c1d9-f0f6-4595-82dd-f656bff974f1 -
UNII
I9ZF7L6G2L -
RxCUI
1812011 -
RxCUI
1812013 -
RxCUI
1812015
What the source publishes
- Labeler
- Ascend Laboratories, LLC
- Active ingredients
- Nifedipine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Nifedipine",
"splId": "2833cb85-4017-41e2-aa4a-c19371ba85e8",
"labels": [
{
"setId": "f661c1d9-f0f6-4595-82dd-f656bff974f1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f661c1d9-f0f6-4595-82dd-f656bff974f1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f661c1d9-f0f6-4595-82dd-f656bff974f1"
}
],
"routes": [
"ORAL"
],
"labeler": "Ascend Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-756-01)",
"package_ndc": "67877-756-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220330"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-756-05)",
"package_ndc": "67877-756-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20220330"
},
{
"sample": false,
"description": "300 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-756-58)",
"package_ndc": "67877-756-58",
"identifierStatus": "well-formed",
"marketing_start_date": "20221230"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-756-90)",
"package_ndc": "67877-756-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20220330"
}
],
"productId": "67877-756_2833cb85-4017-41e2-aa4a-c19371ba85e8",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "67877-756",
"deaSchedule": null,
"genericName": "Nifedipine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NIFEDIPINE",
"strength": "90 mg/1"
}
],
"applicationNumber": "ANDA216067",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220330",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000069",
"N0000175421",
"M0006414"
],
"upc": [
"0367877758589"
],
"unii": [
"I9ZF7L6G2L"
],
"rxcui": [
"1812011",
"1812013",
"1812015"
],
"spl_set_id": [
"f661c1d9-f0f6-4595-82dd-f656bff974f1"
],
"pharm_class_cs": [
"Dihydropyridines [CS]"
],
"pharm_class_epc": [
"Dihydropyridine Calcium Channel Blocker [EPC]"
],
"pharm_class_moa": [
"Calcium Channel Antagonists [MoA]"
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67877-756_2833cb85-4017-41e2-aa4a-c19371ba85e8"